Showing results (591-600 of 693) with videos related to

Sort By:
Pageof 70
Leukemia Research|June 19, 2013
Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)Eyal C Attar, Philip C Amrein, James W Fraser, et al.
Clinical Nutrition ESPEN|May 22, 2024
LLL 44-1 Micronutrients in clinical nutrition: Trace elementsAlan Shenkin, Dinesh Talwar, Nawfel Ben-Hamouda, et al.
Open Heart|January 12, 2025
Evaluation of three diagnostic algorithms to reduce normal scan rates, radiation exposure and costs in patients with suspected chronic coronary syndrome referred for 82Rb-Positron Emission Tomography (82Rb-PET)Simon M Frey, Gabrielle Huré, Jan-Philipp Leibfarth, et al.
Aging Cell|November 16, 2011
The p66Shc knocked out mice are short lived under natural conditionMarco Giorgio, Alessandra Berry, Ina Berniakovich, et al.
Cancer|August 24, 2005
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinomaPhilip C Amrein, John R Clark, Jeffrey G Supko, et al.
Blood|December 2, 2004
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222Joseph O Moore, Stephen L George, Richard K Dodge, et al.
European Journal of Endocrinology|October 1, 2025
Advances in the clinical management of parathyroid disorders: report from the 2024 workshop by the ESE educational program on parathyroid disordersLuís Miguel Cardoso, Lars Rolighed, Karin Amrein, et al.
European Heart Journal. Cardiovascular Imaging|April 9, 2024
Combining anatomical and biochemical markers in the detection and risk stratification of coronary artery diseaseMiriam Albus, Tobias Zimmermann, Daniela Median, et al.
Critical Care (London, England)|November 29, 2022
Serum biomarkers identify critically ill traumatic brain injury patients for MRISophie Richter, Stefan Winzeck, Endre Czeiter, et al.
Cells|April 25, 2020
Circulating Brain Injury Exosomal Proteins following Moderate-To-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy ImplicationsStefania Mondello, Vivian A Guedes, Chen Lai, et al.
Pageof 70